Biovie (BIVI) Liabilities and Shareholders Equity (2013 - 2026)
Biovie's Liabilities and Shareholders Equity was $14.25 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 33.9% from $21.56 million a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
From fiscal Q4 2013 onward, Biovie has reported Liabilities and Shareholders Equity for 50 quarters.
- Liabilities and Shareholders Equity has now declined for three consecutive fiscal years, though with a five-year compound annual growth rate of 18.7% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $21.56 million in FY2025 (-14.5%), $25.21 million in FY2024 (-28.2%), $35.1 million in FY2023 (+74.5%) and $20.11 million in FY2022 (+232.7%).
- The fiscal Q4 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity since fiscal Q4 2021.
- Compared with a year earlier, Liabilities and Shareholders Equity has declined for three straight quarters, with an average decline of 9.6% over the last eight quarters.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q4 2022 (growth of 232.7%); the worst was fiscal Q2 2024 (a decline of 54.5%).
- Per Business Quant data, BIVI's Liabilities and Shareholders Equity in the three fiscal quarters before Q4 2026 was $17.51 million (Q3 2026), $22.5 million (Q2 2026) and $26.82 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - | 14.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.25 Mn |
| Mar 31, 2026 | 17.51 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 26.82 Mn |
| Jun 30, 2025 | 21.56 Mn |
| Mar 31, 2025 | 24.66 Mn |
| Dec 31, 2024 | 25.69 Mn |
| Sep 30, 2024 | 21.24 Mn |
| Jun 30, 2024 | 25.21 Mn |
| Mar 31, 2024 | 31.77 Mn |
| Dec 31, 2023 | 21.49 Mn |
| Sep 30, 2023 | 23.76 Mn |
| Jun 30, 2023 | 35.10 Mn |
| Mar 31, 2023 | 45.18 Mn |
| Dec 31, 2022 | 47.19 Mn |
| Sep 30, 2022 | 22.86 Mn |
| Jun 30, 2022 | 20.11 Mn |
| Mar 31, 2022 | 26.19 Mn |
| Dec 31, 2021 | 31.87 Mn |
| Sep 30, 2021 | 21.98 Mn |
API Access
Biovie Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();